Research Diagnosis Related Groups (DRG) level Readmission quality outcomes for LDS Hospital located at 8 Th Avenue And C St, Salt Lake City, UT, 84143 & includes data from NPIs 1528078581
*Readmission Rate is calculated from October 2016 to August 2019 and all other Quality Outcomes are calculated from October 2016 to September 2019.
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
All Inpatient | 4,583 | 4,398 | ||||||||||
Surgical | 1,757 | 1,733 | ||||||||||
Non Surgical | 2,826 | 2,665 | ||||||||||
Orthopedics | 1,101 | 1,096 | ||||||||||
Psychiatry & Mental Disorders | 715 | 680 | ||||||||||
General Medicine | 663 | 613 | ||||||||||
Gastroenterology & Endocrinology | 382 | 372 | ||||||||||
Pulmonology | 376 | 366 | ||||||||||
General Surgery | 335 | 318 | ||||||||||
Oncology & Hematology | 239 | 217 | ||||||||||
Urology | 233 | 227 | ||||||||||
Cardiovascular | 180 | 161 | ||||||||||
Colorectal | 146 | 141 | ||||||||||
Neurology | 82 | 76 | ||||||||||
Obstetrics & Gynecology | 70 | 70 | ||||||||||
Obesity, Bariatric, Stomach & Duodenal | 50 | 50 |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 469: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Revision Of Hip Or Knee Replacement | ||||||||||||
DRG 467: REVISION OF HIP OR KNEE REPLACEMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 468: REVISION OF HIP OR KNEE REPLACEMENT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Joint And Limb Reattachment Procedures Of Upper Extremity | ||||||||||||
DRG 483: MAJOR JOINT/LIMB REATTACHMENT PROCEDURE OF UPPER EXTREMITIES | ||||||||||||
Hip And Femur Procedures Except Major Joint | ||||||||||||
DRG 481: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 482: HIP AND FEMUR PROCEDURES EXCEPT MAJOR JOINT WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lower Extremity And Humerus Procedures Except Hip,Foot,Femur | ||||||||||||
Knee Procedures | ||||||||||||
DRG 489: KNEE PROCEDURES WITHOUT PDX OF INFECTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Fractures Of Hip And Pelvis |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychoses | ||||||||||||
DRG 885: PSYCHOSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence | ||||||||||||
DRG 897: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 896: ALCOHOL, DRUG ABUSE OR DEPENDENCE WITHOUT REHABILITATION THERAPY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Depressive Neuroses | ||||||||||||
DRG 881: DEPRESSIVE NEUROSES | ||||||||||||
Alcohol/Drug Abuse Or Dependence, Left Ama | ||||||||||||
DRG 894: ALCOHOL, DRUG ABUSE OR DEPENDENCE, LEFT AMA | ||||||||||||
Disorders Of Personality And Impulse Control | ||||||||||||
DRG 883: DISORDERS OF PERSONALITY AND IMPULSE CONTROL |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Septicemia Or Severe Sepsis | ||||||||||||
DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Poisoning And Toxic Effects Of Drugs | ||||||||||||
DRG 917: POISONING AND TOXIC EFFECTS OF DRUGS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 918: POISONING AND TOXIC EFFECTS OF DRUGS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cellulitis | ||||||||||||
DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Complications Of Treatment | ||||||||||||
DRG 920: COMPLICATIONS OF TREATMENT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Signs And Symptoms |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
G.I.Hemorrhage | ||||||||||||
DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
G.I. Obstruction | ||||||||||||
DRG 390: G.I. OBSTRUCTION WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 389: G.I. OBSTRUCTION WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 388: G.I. OBSTRUCTION WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Other Digestive System Diagnoses | ||||||||||||
DRG 394: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Cholecystectomy | ||||||||||||
DRG 418: LAPAROSCOPIC CHOLECYSTECTOMY WITHOUT C.D.E. WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Disorders Of Biliary Tract | ||||||||||||
Disorders Of Pancreas Except Malignancy | ||||||||||||
DRG 439: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Diabetes | ||||||||||||
Major Gastrointestinal Disorders And Peritoneal Infections |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Pulmonary Edema And Respiratory Failure | ||||||||||||
DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
Simple Pneumonia And Pleurisy | ||||||||||||
DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chronic Obstructive Pulmonary Disease | ||||||||||||
DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Respiratory Infections And Inflammations | ||||||||||||
DRG 177: RESPIRATORY INFECTIONS AND INFLAMMATIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Pulmonary Embolism | ||||||||||||
DRG 175: PULMONARY EMBOLISM WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 176: PULMONARY EMBOLISM WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Respiratory System Diagnosis With Ventilator Support | ||||||||||||
DRG 208: RESPIRATORY SYSTEM DIAGNOSIS W VENTILATOR SUPPORT <=96 HOURS | ||||||||||||
Bronchitis And Asthma |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 854: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Respiratory System O.R. Procedures | ||||||||||||
DRG 166: OTHER RESPIRATORY SYSTEM O.R. PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Wound Debridement And Skin Graft Except Hand, For Musculoskeletal And Connective Tissue Disorders | ||||||||||||
DRG 464: WOUND DEBRIDEMENT AND SKIN GRAFT EXCEPT HAND FOR MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Autologous Bone Marrow Transplant Or T-Cell Immunotherapy | ||||||||||||
DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Allogeneic Bone Marrow Transplant | ||||||||||||
DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | ||||||||||||
Hernia Procedures | ||||||||||||
Peritoneal Adhesiolysis | ||||||||||||
Other Skin, Subcutaneous Tissue And Breast Procedures | ||||||||||||
Non-Extensive Procedure Unrelated To Principal Diagnosis |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Acute Leukemia Without Major Procedure | ||||||||||||
DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 835: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Chemotherapy | ||||||||||||
DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 838: CHEMOTHERPY WITH ACUTE LEUKEMIA AS SDX WITH COMPLICATION OR COMORBIDITY (CC) OR HIGH DOSE CHEMOTHERAPY AGENT | ||||||||||||
DRG 839: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Lymphoma And Non-Acute Leukemia | ||||||||||||
DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Hematological/Immunological Diagnoses Except Sickle Cell Crisis And Coagulation | ||||||||||||
DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Red Blood Cell Disorders | ||||||||||||
Chemotherapy Without Acute Leukemia As Secondary Diagnosis | ||||||||||||
Digestive Malignancy |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Renal Failure | ||||||||||||
DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Urinary Tract Infections | ||||||||||||
DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Major Male Pelvic Procedures | ||||||||||||
DRG 708: MAJOR MALE PELVIC PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
Kidney And Ureter Procedures | ||||||||||||
Other Kidney And Urinary Tract Diagnoses | ||||||||||||
DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Heart Failure And Shock | ||||||||||||
DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Circulatory System Diagnoses | ||||||||||||
Peripheral Vascular Disorders |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Major Small And Large Bowel Procedures | ||||||||||||
DRG 330: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
DRG 331: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 329: MAJOR SMALL AND LARGE BOWEL PROCEDURES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Nonspecific Cerebrovascular Disorders | ||||||||||||
DRG 071: NONSPECIFIC CEREBROVASCULAR DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Other Disorders Of Nervous System | ||||||||||||
Intracranial Hemorrhage Or Cerebral Infarction |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Uterine And Adnexal Procedures For Malignancy |
Total Hospitalizations (Oct 2016 to Sep 2019) | Total Hospitalizations After Exclusion | Total Users | Readmission Rate(%) | Utah Total Hospitalizations (Oct 2016 to Sep 2019) | Utah Total Hospitalizations After Exclusion | Utah Total Users | Utah Readmission Rate(%) | National Total Hospitalizations ( Oct 2016 to Sep 2019) | National Total Hospitalizations After Exclusion | National Total Users | National Readmission Rate(%) | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Stomach, Esophageal And Duodenal Procedures | ||||||||||||
DRG 328: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
DRG 327: STOMACH, ESOPHAGEAL AND DUODENAL PROCEDURES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
Procedures For Obesity | ||||||||||||
DRG 621: O.R. PROCEDURES FOR OBESITY WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) |